PRE Prenetics Global Limited
Healthcare$17.81+6.20%ClosedMarket Cap: $302.8M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
1.54
P/S
3.00
EV/EBITDA
-6.22
DCF Value
$-1,259.54
FCF Yield
-7.7%
Div Yield
0.0%
Margins & Returns
Gross Margin
53.0%
Operating Margin
-41.3%
Net Margin
-61.3%
ROE
-36.0%
ROA
-28.7%
ROIC
-22.1%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 null | $36.6M | 59.5% | $-12.4M | $-28.1M | $— | — |
| FY null | $92.4M | 52.8% | $-38.1M | $-37.7M | $— | — |
| Q3 null | $23.6M | 59.5% | $-6.2M | $-7.4M | $— | — |
| Q2 null | $17.7M | 41.2% | $-10.1M | $-12.4M | $— | — |
| Q1 null | $17.3M | 42.4% | $-10.6M | $-10.4M | $— | — |
| Q4 null | $10.5M | 37.2% | $-16.6M | $-16.3M | $— | — |
| FY null | $30.6M | 50.3% | $-48.1M | $-46.3M | $— | — |
| Q3 null | $7.8M | 50.8% | $-11.8M | $-10.7M | $— | — |
| Q2 null | $5.9M | 63.4% | $-10.6M | $-10.7M | $— | — |
| Q1 null | $6.4M | 59.0% | $-9.2M | $-8.6M | $— | — |
| Q4 2023 | $5.3M | 49.2% | $-11.5M | $-16.9M | $-1.57 | — |
| FY null | $21.7M | 40.6% | $-51.9M | $-62.7M | $— | — |